Syndax Pharmaceuticals, Inc. Adjustment of Warrants Granted for Services
Syndax Pharmaceuticals, Inc. (SNDX) reported Adjustment of Warrants Granted for Services of -$1.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-11-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2023-11-02
- Syndax Pharmaceuticals, Inc. adjustment of warrants granted for services for the quarter ending 2023-06-30 was -$1.00K.
| Period end | Adjustment of Warrants Granted for Services 3 month |
|---|---|
| 2023-06-30 | -$1.00K 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |